Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $18.35 Analyst target: $27.58 Upside: 50.30%
Relay Therapeutics, Inc. is a clinical-stage precision drug company. The company is headquartered in Cambridge, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.